Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
Newsletters
Training
White Papers
Advertising
Contact Us
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > FDAnews Device Daily Bulletin > Functional Magnetic Resonance Imaging to Evaluate Pancreatic Cancer

FDAnews Device Daily Bulletin

Aug. 2, 2010 | Vol. 7 No. 149

Functional Magnetic Resonance Imaging to Evaluate Pancreatic Cancer

A recent U.S. study found that advanced magnetic resonance imaging methods could be used to differentiate living from dead tumor cells in a rabbit model of pancreatic cancer, thus providing a more in-depth understanding of this model of pancreatic cancer as well as the imaging methods employed.
PhysOrg

Register Now
Print This Page
Email This Article
RSS
Archives

Related Articles

Abbott Receives FDA Approval for Test to Assess Hepatitis B Treatment InfraReDx Gets OK to Market Imaging System PerkinElmer Pulls in $500 Million From Sales of IDS Unit BSD Medical Tissue Device Is Safety Compliant

Home
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.